Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tom Drolet who wrote (3186)	1/23/2000 1:10:00 PM
From: Mike Jubian	Read Replies (2) of 14101

Mark, Tom, "While there are others with great prospects (Biomira and Hemosol, to name two) none are as close to actually making money as DMX." Just looking at TSE 300 composite index, Biotech/Pharma 1) Biochem Pharma with 4.4 Billion M/Cap and EPS of 1.27 2) Biovail with 4.9 Billion M/Cap and EPS of 1.53 3) QLT Photo. with 6.9 Billion M/Cap and EPS of -.50 (just to compare, DMX just under 200 Million M/Cap and EPS of -.37) My point is making money doesn't necessarily mean your worth more. What makes QLT so special and more valuable then BCH and BVF? I have read past posts mentioning that DMX has a greater market then QLT. Would it be safe to say DMX will out perform QLT? How can we justify what a company is worth? I know we need more buyers, but whose responsibility is that? PS: don't pay too much attention to me, this is my second day on the patch. If smoking is not going to kill me quitting is. I think I'll go to Home Depot and finish the basement. MJ

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next